 | • レポートコード：TPM-NV128 • 出版社/出版日：Transparency Market Research / 2019年11月8日 • レポート形態：英文、PDF、191ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、ポイントオブケア凝固試験装置の世界市場について調べ、ポイントオブケア凝固試験装置の世界市場規模、市場動向、市場シェア、市場環境、市場予測、製品別（計器/分析装置、消耗品および付属品）分析、方法別（PT / INR、粘弾性凝固モニタリング、その他）分析、エンドユーザー別（病院、診断研究所、クリニック、その他）分析、関連企業情報などをまとめました。 ・ポイントオブケア凝固試験装置の市場概要 ・ポイントオブケア凝固試験装置の市場動向 ・ポイントオブケア凝固試験装置の価格分析 ・ポイントオブケア凝固試験装置の世界市場規模・予測 ・ポイントオブケア凝固試験装置市場：製品別（計器/分析装置、消耗品および付属品） ・ポイントオブケア凝固試験装置市場：方法別（PT / INR、粘弾性凝固モニタリング、その他） ・ポイントオブケア凝固試験装置市場：方法別（PT / INR、粘弾性凝固モニタリング、その他） ・地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争環境・関連企業分析 |
Healthcare companies in the point-of-care coagulation testing devices market are developing analyzers that meet the quality control standards laid down by central laboratories. They are increasing expertise in the development of POC (point-of-care) devices that generate timely results. With the surging trend of self-monitoring, patients can be assured of lab-accurate PT/INR (Prothrombin Time/International Normalized Ratio) results, with advancements in POC coagulation testing systems. As such, healthcare companies in the point-of-care coagulation testing devices market are developing mobile handheld devices that help improve outcomes and serve the convenience of patients who have undergone major surgeries.
Several advantages of POC coagulation testing are adding value for patients regarding hemostatic management, both, in and out of the hospital. Currently, manufacturers in the point-of-care coagulation testing devices landscape are creating the increased availability of POC devices for hospitals, since hospitals hold the highest revenue share amongst all the end-users in the landscape, with a value of ~US$ 500 million in 2018. Thus, during emergency cases in ICUs, coronary care units, and during surgeries, POC devices help provide immediate and actionable results to healthcare providers. As such, healthcare companies in the point-of-care coagulation testing devices market are tapping into incremental opportunities by expediting hemostasis management amongst patients in a range of settings, such as outpatient clinics, physician offices, pharmacies, and healthcare centres. For instance, in April 2018, Roche – a Swiss multinational healthcare company, announced the launch of CoaguChek® Vantus system, a self-testing device, enabled with the wireless reporting of INR results.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Point-of-Care Coagulation Testing Devices
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Point-of-Care Coagulation Testing Devices Analysis and Forecasts, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Forces Analysis
5. Key Insights
5.1. Key Events
5.2. Pricing Analysis
5.3. Technology Advancements
6. Global Point-of-Care Coagulation Testing Devices Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
6.3.1. Instruments/Analyzers
6.3.2. Consumables and Accessories
6.4. Global Point-of-Care Coagulation Testing Devices Market Attractiveness, by Product
7. Global Point-of-Care Coagulation Testing Devices Analysis and Forecasts, by Method
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027
7.3.1. PT/INR
7.3.2. Others
7.3.3. Viscoelastic Coagulation Monitoring
7.4. Global Point-of-Care Coagulation Testing Devices Market Attractiveness, by Method
8. Global Point-of-Care Coagulation Testing Devices Analysis and Forecasts, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Clinics
8.3.4. Others
8.4. Global Point-of-Care Coagulation Testing Devices Market Attractiveness, by End-user
9. Global Point-of-Care Coagulation Testing Devices Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Global Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Point-of-Care Coagulation Testing Devices Market Attractiveness by Region
10. North America Point-of-Care Coagulation Testing Devices Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
10.2.1. Instruments/Analyzers
10.2.2. Consumables and Accessories
10.3. North America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027
10.3.1. PT/INR
10.3.2. Others
10.3.3. Viscoelastic Coagulation Monitoring
10.4. North America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Clinics
10.4.4. Others
10.5. North America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Method
10.6.3. By End-user
10.6.4. By Country
11. Europe Point-of-Care Coagulation Testing Devices Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
11.2.1. Instruments/Analyzers
11.2.2. Consumables and Accessories
11.3. Europe Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027
11.3.1. PT/INR
11.3.2. Others
11.3.3. Viscoelastic Coagulation Monitoring
11.4. Europe Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Clinics
11.4.4. Others
11.5. Europe Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Method
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Point-of-Care Coagulation Testing Devices Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
12.2.1. Instruments/Analyzers
12.2.2. Consumables and Accessories
12.3. Asia Pacific Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027
12.3.1. PT/INR
12.3.2. Others
12.3.3. Viscoelastic Coagulation Monitoring
12.4. Asia Pacific Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Clinics
12.4.4. Others
12.5. Asia Pacific Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Method
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Point-of-Care Coagulation Testing Devices Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
13.2.1. Instruments/Analyzers
13.2.2. Consumables and Accessories
13.3. Latin America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027
13.3.1. PT/INR
13.3.2. Others
13.3.3. Viscoelastic Coagulation Monitoring
13.4. Latin America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Clinics
13.4.4. Others
13.5. Latin America Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Method
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Point-of-Care Coagulation Testing Devices Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Product, 2017–2027
14.2.1. Instruments/Analyzers
14.2.2. Consumables and Accessories
14.3. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Method, 2017–2027
14.3.1. PT/INR
14.3.2. Others
14.3.3. Viscoelastic Coagulation Monitoring
14.4. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Clinics
14.4.4. Others
14.5. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Method
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competitive Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Rank Analysis by Company (2018)
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. F. Hoffmann-La Roche AG
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Company Financials
15.4.1.3. Growth Strategies
15.4.1.4. SWOT Analysis
15.4.2. Abbott Laboratories
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Company Financials
15.4.2.3. Growth Strategies
15.4.2.4. SWOT Analysis
15.4.3. Siemens Healthineers
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Company Financials
15.4.3.3. Growth Strategies
15.4.3.4. SWOT Analysis
15.4.4. Medtronic plc
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Company Financials
15.4.4.3. Growth Strategies
15.4.4.4. SWOT Analysis
15.4.5. Haemonetics Corporation
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Company Financials
15.4.5.3. Growth Strategies
15.4.5.4. SWOT Analysis
15.4.6. HemoSonics, LLC
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Growth Strategies
15.4.6.3. SWOT Analysis
15.4.7. Micropoint Bioscience, Inc.
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Growth Strategies
15.4.7.3. SWOT Analysis
15.4.8. Werfen
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2. Company Financials
15.4.8.3. Growth Strategies
15.4.8.4. SWOT Analysis
15.4.9. Sienco, Inc.
15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.9.2. Growth Strategies
15.4.9.3. SWOT Analysis
15.4.10. Koninklijke Philips N.V.
15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.10.2. Company Financials
15.4.10.3. Growth Strategies
15.4.10.4. SWOT Analysis